Document/ExhibitDescriptionPagesSize
1: 10-K Annual Report HTML 2.26M
2: EX-21.1 Subsidiaries List HTML 52K
3: EX-23.1 Consent of Expert or Counsel HTML 26K
6: EX-97 Clawback Policy re: Recovery of Erroneously HTML 45K Awarded Compensation
4: EX-31.1 Certification -- §302 - SOA'02 HTML 32K
5: EX-32.1 Certification -- §906 - SOA'02 HTML 29K
12: R1 Cover HTML 98K
13: R2 Audit Information HTML 32K
14: R3 Consolidated Balance Sheets HTML 149K
15: R4 Consolidated Balance Sheets (Parentheticals) HTML 44K
16: R5 Consolidated Statements of Income HTML 111K
17: R6 Consolidated Statements of Comprehensive Income HTML 56K
18: R7 Consolidated Statements of Cash Flows HTML 103K
19: R8 Consolidated Statements of Changes in HTML 72K
Stockholders' Equity
20: R9 Significant Accounting Policies HTML 111K
21: R10 Fair Value Measurements and Investments HTML 220K
22: R11 Goodwill and Other Purchased Intangible Assets HTML 108K
23: R12 Inventory HTML 36K
24: R13 Property, Plant, and Equipment, Net HTML 39K
25: R14 Notes Payable and Long-Term Debt HTML 48K
26: R15 Income Taxes HTML 128K
27: R16 Stockholders' Equity HTML 61K
28: R17 Accumulated Other Comprehensive Income (Loss) HTML 54K
29: R18 Share-Based Compensation/Equity Awards and HTML 105K
Purchase Plans
30: R19 Other Income, Net HTML 45K
31: R20 Supplemental Cash Flow Information HTML 71K
32: R21 Commitments and Contingent Liabilities HTML 93K
33: R22 Legal Proceedings HTML 29K
34: R23 Segment Information HTML 106K
35: R24 Restructuring Costs HTML 96K
36: R25 Leases HTML 87K
37: R26 Quarterly Financial Data (Unaudited) HTML 53K
38: R27 Subsequent Events HTML 29K
39: R28 Pay vs Performance Disclosure HTML 40K
40: R29 Insider Trading Arrangements HTML 33K
41: R30 Significant Accounting Policies (Policies) HTML 184K
42: R31 Significant Accounting Policies (Tables) HTML 65K
43: R32 Fair Value Measurements and Investments (Tables) HTML 224K
44: R33 Goodwill and Other Purchased Intangible Assets HTML 112K
(Tables)
45: R34 Inventory (Tables) HTML 36K
46: R35 Property, Plant, and Equipment, Net (Tables) HTML 38K
47: R36 Notes Payable and Long-Term Debt (Tables) HTML 48K
48: R37 Income Taxes (Tables) HTML 128K
49: R38 Stockholders' Equity (Tables) HTML 61K
50: R39 Accumulated Other Comprehensive Income (Loss) HTML 53K
(Tables)
51: R40 Share-Based Compensation/Equity Awards and HTML 103K
Purchase Plans (Tables)
52: R41 Other Income, Net (Tables) HTML 44K
53: R42 Supplemental Cash Flow Information (Tables) HTML 71K
54: R43 Commitments and Contingent Liabilities (Tables) HTML 95K
55: R44 Segment Information (Tables) HTML 106K
56: R45 Restructuring Costs (Tables) HTML 96K
57: R46 Leases (Tables) HTML 91K
58: R47 Quarterly Financial Data (Unaudited) (Tables) HTML 55K
59: R48 Significant Accounting Policies - Property, Plant HTML 66K
and Equipment (Details)
60: R49 Significant Accounting Policies - Amortization of HTML 53K
Intangible Assets (Details)
61: R50 Significant Accounting Policies - Warranty HTML 34K
rollforward (Details)
62: R51 Significant Accounting Policies - Earnings per HTML 37K
share (Details)
63: R52 Significant Accounting Policies - Revenue HTML 41K
Recognition (Details)
64: R53 Significant Accounting Policies (Details) HTML 44K
65: R54 Fair Value Measurements and Investments (Details) HTML 227K
66: R55 Fair Value Measurements and Investments Foreign HTML 36K
Exchange Forward Contracts (Details)
67: R56 Fair Value Measurements and Investments HTML 78K
Available-for-Sale Investments (Details)
68: R57 Fair Value Measurements and Investments Amortized HTML 48K
Cost and Fair Value of Debt Securities (Details)
69: R58 Fair Value Measurements and Investments Fair Value HTML 63K
and Gross Unrealized Losses with Unrealized Losses
(Details)
70: R59 Fair Value Measurements and Investments (Details) HTML 62K
71: R60 Fair Value Measurements and Investments Fair Value HTML 48K
of Long-Term Debt (Details)
72: R61 Goodwill and Other Purchased Intangible Assets HTML 56K
Intangible Assets, Goodwill and Other (Details)
73: R62 Goodwill and Other Purchased Intangible Assets HTML 91K
Intangible Assets, Goodwill and Other Intangible
Assets (Details)
74: R63 Inventory (Details) HTML 36K
75: R64 Property, Plant, and Equipment, Net (Details) HTML 42K
76: R65 Notes Payable and Long-Term Debt - Principal HTML 61K
Components of Long-Term Debt (Details)
77: R66 Notes Payable and Long-Term Debt - Narrative HTML 72K
(Details)
78: R67 Notes Payable and Long-Term Debt - Maturity HTML 47K
Schedule (Details)
79: R68 Income Taxes (Details) HTML 170K
80: R69 Stockholders' Equity (Details) HTML 50K
81: R70 Stockholders' Equity Treasury Shares (Details) HTML 48K
82: R71 Accumulated Other Comprehensive Income (Loss) HTML 65K
(Details)
83: R72 Accumulated Other Comprehensive Income (Loss) HTML 32K
Reclassification out of Accumulated Other
Comprehensive Income (Details)
84: R73 Share-Based Compensation/Equity Awards and HTML 162K
Purchase Plans (Details)
85: R74 Share-Based Compensation/Equity Awards and HTML 82K
Purchase Plans (Details)
86: R75 Other Income, Net (Details) HTML 43K
87: R76 Supplemental Cash Flow Information (Details) HTML 92K
88: R77 Commitments and Contingent Liabilities (Details) HTML 76K
89: R78 Commitments and Contingent Liabilities Period HTML 31K
Expense (Details)
90: R79 Commitments and Contingent Liabilities (Details) HTML 113K
91: R80 Segment Information (Details) HTML 69K
92: R81 Segment Information Segment Profit Reconciliation HTML 56K
(Details)
93: R82 Segment Information Segment Asset Reconciliation HTML 50K
(Details)
94: R83 Segment Information Segment Information by HTML 44K
Geographical Location (Details)
95: R84 Restructuring Costs (Details) HTML 99K
96: R85 Leases (Details) HTML 137K
97: R86 Quarterly Financial Data (Unaudited) (Details) HTML 84K
98: R87 Subsequent Events (Details) HTML 32K
100: XML IDEA XML File -- Filing Summary XML 189K
103: XML XBRL Instance -- bio-20231231_htm XML 3.91M
99: EXCEL IDEA Workbook of Financial Report Info XLSX 232K
8: EX-101.CAL XBRL Calculations -- bio-20231231_cal XML 205K
9: EX-101.DEF XBRL Definitions -- bio-20231231_def XML 1.27M
10: EX-101.LAB XBRL Labels -- bio-20231231_lab XML 2.80M
11: EX-101.PRE XBRL Presentations -- bio-20231231_pre XML 1.72M
7: EX-101.SCH XBRL Schema -- bio-20231231 XSD 172K
101: JSON XBRL Instance as JSON Data -- MetaLinks 804± 1.21M
102: ZIP XBRL Zipped Folder -- 0000012208-24-000013-xbrl Zip 750K
‘EX-97’ — Clawback Policy re: Recovery of Erroneously Awarded Compensation
POLICY FOR RECOVERY OF ERRONEOUSLY AWARDED COMPENSATION
Bio-Rad Laboratories, Inc. (the “Company”) has adopted this Policy for Recovery of Erroneously Awarded Compensation (the “Policy”), effective as of October 2, 2023 (the “Effective Date”). Capitalized
terms used in this Policy but not otherwise defined in the text of this Policy are defined in Section 11.
1.Persons Subject to Policy
This Policy shall apply to current and former Officers of the Company. Each Officer shall be required to sign an Acknowledgement Agreement pursuant to which such Officer will agree to be bound by the terms of, and comply with, this Policy; however, any Officer’s failure to sign any such Acknowledgment Agreement shall not negate the application of this Policy to the Officer.
2. Compensation Subject to Policy
This Policy shall apply to Incentive-Based Compensation received on or after the Effective Date. For purposes of this Policy, the date
on which Incentive-Based Compensation is “received” shall be determined under the Applicable Rules, which generally provide that Incentive-Based Compensation is “received” in the Company’s fiscal period during which the relevant Financial Reporting Measure is attained or satisfied, without regard to whether the grant, vesting or payment of the Incentive-Based Compensation occurs after the end of that period.
3. Recovery of Compensation
In the event that the Company is required to prepare a Restatement, the Company shall recover, reasonably promptly, the portion of any Incentive-Based Compensation that
is Erroneously Awarded Compensation, unless the Committee has determined that recovery would be Impracticable. Recovery shall be required in accordance with the preceding sentence regardless of whether the applicable Officer engaged in misconduct or otherwise caused or contributed to the requirement for the Restatement and regardless of whether or when restated financial statements are filed by the Company. For clarity, the recovery of Erroneously Awarded Compensation under this Policy will not give rise to any person’s right to voluntarily terminate employment for “good reason,” or due to a “constructive termination” (or any similar term of like effect) under any plan, program or policy of or agreement with the Company or any of its affiliates.
Board
Approved 10-20-2023
1
4. Manner of Recovery; Limitation on Duplicative Recovery
The Committee shall, in its sole discretion, determine the manner of recovery of any Erroneously Awarded Compensation, which may include, without limitation, reduction or cancellation by the Company or an affiliate of the Company of Incentive-Based Compensation or Erroneously Awarded Compensation, reimbursement or repayment by any person subject to this Policy of the Erroneously Awarded Compensation, and, to the extent permitted by law, an offset of the Erroneously
Awarded Compensation against other compensation payable by the Company or an affiliate of the Company to such person. Notwithstanding the foregoing, unless otherwise prohibited by the Applicable Rules, to the extent this Policy provides for recovery of Erroneously Awarded Compensation already recovered by the Company pursuant to Section 304 of the Sarbanes-Oxley Act of 2002 or Other Recovery Arrangements, the amount of Erroneously Awarded Compensation already recovered by the Company from the recipient of such Erroneously Awarded Compensation will be credited to the amount of Erroneously Awarded Compensation required to be recovered pursuant
to this Policy from such person.
5. Administration
This Policy shall be administered, interpreted and construed by the Committee, which is authorized to make all determinations necessary, appropriate or advisable for such purpose. The Board of Directors of the Company (the “Board”) may re-vest in itself the authority to administer, interpret and construe this Policy in accordance with applicable law, and in such event references herein to the “Committee” shall be deemed to be references to the Board. Subject to any permitted review by the applicable national securities exchange or association pursuant to the Applicable Rules, all determinations and decisions made by the Committee pursuant to the provisions of this Policy
shall be final, conclusive and binding on all persons, including the Company and its affiliates, equityholders and employees. The Committee may delegate administrative duties with respect to this Policy to one or more directors or employees of the Company, as permitted under applicable law, including any Applicable Rules.
6. Interpretation
This Policy will be interpreted and applied in a manner that is consistent with the requirements of the Applicable Rules, and to the extent this Policy is inconsistent with such Applicable Rules, it shall be deemed amended to the minimum extent necessary to ensure compliance therewith.
7. No
Indemnification; No Personal Liability
The Company shall not indemnify or insure any person against the loss of any Erroneously Awarded Compensation pursuant to this Policy, nor shall the Company directly or indirectly pay or reimburse any person for any premiums for third-party insurance policies that such person may elect to purchase to fund such person’s potential obligations under this Policy. No member of the Committee or the Board shall have any personal liability to any person as a result of actions taken under this Policy and each member of the Committee and the Board shall be fully indemnified by the Company to the fullest extent under applicable law and Company policy with
respect to any actions taken under this Policy. The foregoing sentence shall not limit any other rights to indemnification of the members of the Board under applicable law or Company policy.
8. Application; Enforceability
2
Except as otherwise determined by the Committee or the Board, the adoption of this Policy does not limit, and is intended to apply in addition to, any other clawback, recoupment, forfeiture or similar policies or provisions of the Company or its affiliates, including any such policies or provisions of such effect contained in any employment
agreement, bonus plan, incentive plan, equity-based plan or award agreement thereunder or similar plan, program or agreement of the Company or an affiliate or required under applicable law (the “Other Recovery Arrangements”). The remedy specified in this Policy shall not be exclusive and shall be in addition to every other right or remedy at law or in equity that may be available to the Company or an affiliate of the Company.
9. Severability
The provisions in this Policy are intended to be applied to the fullest extent of the law; provided, however, to the extent that
any provision of this Policy is found to be unenforceable or invalid under any applicable law, such provision will be applied to the maximum extent permitted, and shall automatically be deemed amended in a manner consistent with its objectives to the extent necessary to conform to any limitations required under applicable law.
10. Amendment and Termination
The Board or the Committee may amend, modify or terminate this Policy in whole or in part at any time and from time to time in its sole discretion. This Policy will terminate automatically when the Company does not have a class of securities listed on a national securities exchange or association.
11. Definitions
“Applicable
Rules” means Section 10D of the Exchange Act, Rule 10D-1 promulgated thereunder, the listing rules of the national securities exchange or association on which the Company’s securities are listed, and any applicable rules, standards or other guidance adopted by the Securities and Exchange Commission or any national securities exchange or association on which the Company’s securities are listed.
“Committee” means the Compensation Committee of the Board so long as such committee is comprised solely of independent directors (as determined under the Applicable Rules), or in the absence of such a committee, a majority of the independent directors serving on the Board.
“Erroneously
Awarded Compensation” means the amount of Incentive-Based Compensation received by a current or former Officer that exceeds the amount of Incentive-Based Compensation that would have been received by such current or former Officer based on a restated Financial Reporting Measure, as determined on a pre-tax basis in accordance with the Applicable Rules.
“Exchange Act” means the Securities Exchange Act of 1934, as amended.
“Financial Reporting Measure” means any measure determined and presented in accordance with the accounting principles used in preparing the Company’s financial statements, and any measures derived wholly or in part from such measures, including GAAP, IFRS and non-GAAP/IFRS
financial measures, as well as stock or share price and total equityholder return.
3
“GAAP” means United States generally accepted accounting principles.
“IFRS” means international financial reporting standards as adopted by the International Accounting Standards Board.
“Impracticable” means (a) the direct costs paid to third parties to assist in enforcing recovery would exceed the Erroneously Awarded Compensation; provided that the
Company (i) has made reasonable attempts to recover the Erroneously Awarded Compensation, (ii) documented such attempt(s), and (iii) provided such documentation to the relevant listing exchange or association, (b) to the extent permitted by the Applicable Rules, the recovery would violate the Company’s home country laws pursuant to an opinion of home country counsel; provided that the Company has (i) obtained an opinion of home country counsel, acceptable to the relevant listing exchange or association, that recovery would result in such violation, and (ii) provided such opinion to the relevant listing exchange or association, or (c) recovery would likely cause an otherwise tax-qualified retirement plan, under which benefits are broadly available to employees of the
Company, to fail to meet the requirements of 26 U.S.C. 401(a)(13) or 26 U.S.C. 411(a) and the regulations thereunder.
“Incentive-Based Compensation” means, with respect to a Restatement, any compensation that is granted, earned, or vested based wholly or in part upon the attainment of one or more Financial Reporting Measures and received by a person: (a) after beginning service as an Officer; (b) who served as an Officer at any time during the performance period for that compensation; (c) while the issuer has a class of its securities listed on a national securities exchange or association; and (d) during the applicable Three-Year Period.
“Officer” means each person who serves as an executive officer of the Company,
as defined in Rule 10D-1(d) under the Exchange Act.
“Restatement” means an accounting restatement to correct the Company’s material noncompliance with any financial reporting requirement under securities laws, including restatements that correct an error in previously issued financial statements (a) that is material to the previously issued financial statements or (b) that would result in a material misstatement if the error were corrected in the current period or left uncorrected in the current period.
“Three-Year Period” means, with respect to a Restatement, the three completed fiscal years immediately preceding the date that the Board, a committee of the Board, or the officer or officers of the
Company authorized to take such action if Board action is not required, concludes, or reasonably should have concluded, that the Company is required to prepare such Restatement, or, if earlier, the date on which a court, regulator or other legally authorized body directs the Company to prepare such Restatement. The “Three-Year Period” also includes any transition period (that results from a change in the Company’s fiscal year) within or immediately following the three completed fiscal years identified in the preceding sentence. However, a transition period between the last day of the
Company’s previous fiscal year end and the first day of its new fiscal year that comprises a period of nine to 12 months shall be deemed a completed fiscal year.
4
ACKNOWLEDGMENT AND CONSENT TO POLICY FOR RECOVERY OF ERRONEOUSLY AWARDED COMPENSATION
The undersigned has received a copy of the Policy for Recovery of Erroneously Awarded Compensation (as amended from time to time, the “Policy”) adopted by Bio-Rad Laboratories, Inc. (the “Company”).
In consideration of, and as a condition to, the receipt of future cash and equity incentive
compensation from the Company, the undersigned agrees to the terms of the Policy and agrees that compensation received by the undersigned may be subject to reduction, cancellation, forfeiture and/or recoupment to the extent necessary to comply with the Policy, notwithstanding any other agreement to the contrary. The undersigned further acknowledges and agrees that the undersigned is not entitled to indemnification in connection with any enforcement of the Policy and expressly waives any rights to such indemnification under the Company’s organizational documents or otherwise.